false --12-31 2024 Q1 0000888981 0000888981 2024-01-01 2024-03-31 0000888981 2024-05-08 0000888981 2023-01-01 2023-03-31 0000888981 2024-03-31 0000888981 2023-12-31 0000888981 2022-12-31 0000888981 2023-03-31 0000888981 us-gaap:CommonStockMember 2023-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000888981 us-gaap:RetainedEarningsMember 2023-12-31 0000888981 us-gaap:CommonStockMember 2022-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000888981 us-gaap:RetainedEarningsMember 2022-12-31 0000888981 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000888981 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000888981 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000888981 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000888981 us-gaap:CommonStockMember 2024-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000888981 us-gaap:RetainedEarningsMember 2024-03-31 0000888981 us-gaap:CommonStockMember 2023-03-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000888981 us-gaap:RetainedEarningsMember 2023-03-31 0000888981 us-gaap:CommonStockMember 2024-08-18 0000888981 nnup:DueAprilMember 2024-03-31 0000888981 nnup:DueJulyMember 2024-03-31 0000888981 nnup:DueSeptemberMember 2024-03-31 0000888981 2022-01-01 2022-12-31 0000888981 2023-09-10 2023-09-11 0000888981 us-gaap:PrivatePlacementMember 2023-09-10 2023-09-11 0000888981 us-gaap:PrivatePlacementMember 2023-09-11 0000888981 2023-09-11 0000888981 us-gaap:DomesticCountryMember 2024-03-31 0000888981 us-gaap:StateAndLocalJurisdictionMember 2024-03-31 0000888981 nnup:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000888981 nnup:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000888981 nnup:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000888981 nnup:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000888981 nnup:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000888981 nnup:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000888981 srt:NorthAmericaMember 2024-01-01 2024-03-31 0000888981 srt:NorthAmericaMember 2023-01-01 2023-03-31 0000888981 srt:AsiaMember 2024-01-01 2024-03-31 0000888981 srt:AsiaMember 2023-01-01 2023-03-31 0000888981 country:AU 2024-01-01 2024-03-31 0000888981 country:AU 2023-01-01 2023-03-31 0000888981 2019-01-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

Form 10-Q

(Mark One)

 

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

or

 

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________________ to ______________

 

Commission File Number: 000-20333

 

NOCOPI TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Maryland  87-0406496
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

 

480 Shoemaker Road, Suite 104, King of Prussia, PA 19406

(Address of principal executive offices) (Zip Code)

 

(610) 834-9600

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ☐ Accelerated filer   ☐
Non-accelerated filer     ☒ Smaller reporting company  ☒
  Emerging growth company  ☐

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 10,501,178 shares of common stock, par value $0.01, as of May 15, 2024 .

 

 

 

 
 

 

NOCOPI TECHNOLOGIES, INC.

 

INDEX

 

  PAGE
Part I. FINANCIAL INFORMATION  
   
Item 1. Financial Statements 1
   
Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2024 and March 31, 2023 1
Balance Sheets at March 31, 2024 and December 31, 2023 2
Statements of Cash Flows for the Three Months Ended March 31, 2024 and March 31, 2023 3
Statements of Stockholders’ Equity for the Three Months ended March 31, 2024 and March 31, 2023 4
Notes to Financial Statements 5
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 10
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 15
   
Item 4. Controls and Procedures 15
   
Part II. OTHER INFORMATION  
   
Item 1. Legal Proceedings 16
   
Item 1A. Risk Factors 16
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 16
   
Item 3. Defaults Upon Senior Securities 16
   
Item 4. Mine Safety Disclosures 16
   
Item 5. Other Information 16
   
Item 6. Exhibits 16
   
SIGNATURES 17
   

 

 

i 

 
 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Nocopi Technologies, Inc.

Statements of Comprehensive Income (Loss)*

(unaudited)

         
  

Three Months ended

March 31

 
   2024   2023 
Revenues        
Licenses, royalties and fees  $86,500   $123,000 
Product and other sales   311,800    469,100 
 Total revenues   398,300    592,100 
Cost of revenues          
Licenses, royalties and fees   51,800    58,700 
Product and other sales   180,900    221,800 
Total cost of revenues   232,700    280,500 
Gross profit   165,600    311,600 
           
Operating expenses          
Research and development   41,400    44,800 
Sales and marketing   69,000    86,300 
General and administrative   1,214,800    201,200 
Total operating expenses   1,325,200    332,300 
Net loss from operations   (1,159,600)   (20,700)
           
Other income (expenses)          
Interest income   137,100    62,100 
Interest expense and bank charges   (5,700)   (600)
Total other income (expenses)   131,400    61,500 
Net income (loss) before income taxes   (1,028,200)   40,800 
Income taxes   —      10,500 
Net income (loss)  $(1,028,200)  $30,300 
           
Basic net income (loss) per common share  $(.10)  $.00 
Diluted net income (loss) per common share  $(.10)  $.00 
           
Weighted average common shares outstanding          
Basic   10,501,178    9,251,178 
Diluted   10,501,178    9,251,178 

 

*See accompanying notes to these financial statements.

 

 

1 
 

 

Nocopi Technologies, Inc.

Balance Sheets*

(unaudited)

 

         
   March 31   December 31 
   2024   2023 
         
Assets          
Current assets          
Cash  $3,600,100   $2,269,200 
Accounts receivable less $12,000 allowance for credit losses   981,500    1,120,700 
Inventory   370,300    448,000 
Interest receivable   205,100    160,000 
Short-term investments   6,910,900    7,985,600 
Prepaid and other   100,600    121,800 
Total current assets   12,168,500    12,105,300 
           
Fixed assets          
Leasehold improvements   81,500    81,500 
Furniture, fixtures and equipment   177,800    169,800 
Fixed assets, gross   259,300    251,300 
Less: accumulated depreciation and amortization   229,000    214,800 
 Total fixed assets   30,300    36,500 
Other assets          
Long-term receivables   1,701,300    1,838,500 
Operating lease right of use – building   4,400    17,600 
Total other assets   1,705,700    1,856,100 
Total assets  $13,904,500   $13,997,900 
           
Liabilities and Stockholders' Equity          
Current liabilities          
Accounts payable  $47,700   $27,500 
Accrued expenses   120,000    94,600 
Stock compensation payable   2,259,100    1,347,100 
Operating lease liability – current   4,400    17,600 
Total current liabilities   2,431,200    1,486,800 
           
Other liabilities          
Accrued expenses, non-current   119,000    128,600 
Total other liabilities   119,000    128,600 
           
Stockholders' equity          
Common stock, $0.01 par value
Authorized – 75,000,000 shares
Issued and outstanding – 10,501,178 shares		   105,000    105,000 
Paid-in capital   21,647,100    21,647,100 
Accumulated deficit   (10,397,800)   (9,369,600)
Total stockholders' equity   11,354,300    12,382,500 
Total liabilities and stockholders' equity  $13,904,500   $13,997,900 

 

*See accompanying notes to these financial statements.

 

  

2 
 

 

Nocopi Technologies, Inc.

Statements of Cash Flows*

(unaudited)

         
  

Three Months ended

March 31

 
   2024   2023 
Operating Activities          
     Net income (loss)  $(1,028,200)  $30,300 
     Adjustments to reconcile net income (loss) to net cash provided by operating activities          
           Depreciation and amortization   14,200    8,300 
           Stock-based compensation   912,000    —   
           Interest income accrued   (45,100)   —   
    (Increase) decrease in assets          
          Accounts receivable   139,200    (163,700)
          Inventory   77,700    81,000 
          Prepaid and other   21,200    (56,700)
          Long-term receivables   150,400    169,400 
    Increase (decrease) in liabilities          
          Accounts payable and accrued expenses   22,800    (21,500)
          Income taxes   —      10,500 
          Net cash provided by operating activities   264,200    57,600 
           
Investing Activities          
Additions to fixed assets   (8,000)   (1,100)
Sale of short-term investments   1,074,700    —   
Net cash provided by (used in) investing activities   1,066,700    (1,100)
           
Increase in cash and cash equivalents   1,330,900    56,500 
           
Cash and Cash Equivalents          
 Beginning of year   2,269,200    5,337,800 
 End of period  $3,600,100   $5,394,300 

 

*See accompanying notes to these financial statements.

 

 

3 
 

 

Nocopi Technologies, Inc.

Statements of Stockholders’ Equity*

For the Three Months ended March 31, 2024 and March 31, 2023

(unaudited)

 

                     
   Common stock   Paid-in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance at December 31, 2023   10,501,178   $105,000   $21,647,100   $(9,369,600)  $12,382,500 
                          
Net loss        —      —      (1,028,200)   (1,028,200)
Balance at March 31, 2024   10,501,178   $105,000   $21,647,100   $(10,397,800)  $11,354,300 

 

   Common stock   Paid-in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance at December 31, 2022   9,251,178   $92,500   $16,659,600   $(7,933,700)  $8,818,400 
                          
Net income        —      —      30,300    30,300 
Balance at March 31, 2023   9,251,178   $92,500   $16,659,600   $(7,903,400)  $8,848,700 

  

 

* See accompanying notes to these financial statements.

 

 

4 
 

 

 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

 

Note 1. Financial Statements

 

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (our “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in Note 2 Significant Accounting Policies included in the Notes to Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 25, 2024 (the “2023 Annual Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 2023 Annual Report should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months ended March 31, 2024 may not be necessarily indicative of the operating results expected for the full year. 

 

Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income (loss).  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since our Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

 

Recently Issued Accounting Pronouncements Not Yet Adopted

As of March 31, 2024, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Recently Adopted Accounting Pronouncements

As of March 31, 2024 and for the period then ended, there are no recently adopted accounting standards that have a material effect on the Company's financial statements.

Note 2. Stock-Based Compensation

 

Our Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. At March 31, 2024, our Company did not have an active stock option plan. There was no unrecognized portion of expense related to stock option grants at March 31, 2024.

 

As part of an employment agreement, the Company granted an executive a one-time equity award of 1,000,000 restricted shares of the Company’s common stock valued at $3,580,000, fair value, which award shall vest in its entirety on August 18, 2024. The fair market value of the restricted stock award was determined based on the closing price of the Company’s common stock on the grant date and is being amortized on a straight-line basis to general and administrative expense as stock-based compensation over the one-year vesting term. The Company recorded stock-based compensation expense of $890,100 for the three months ended March 31, 2024. To the extent the Company has not established an employee equity compensation plan on or prior to August 18, 2024, the restricted shares may be converted, at the election of the executive, in full or in part, into cash compensation, at a rate of $3.58 per share of common stock, which was the fair market value of the common stock on October 10, 2023, which was the date the Board of Directors approved the grant. Since the issuance of the restricted stock can be settled in cash, the monthly amortization of the $3,580,000 fair value of the restricted stock grant is recorded as stock compensation payable. If the restricted stock grant is settled in shares of the Company’s common stock, then the stock compensation payable will be reclassified to additional paid in capital.

 

 

 
5 
 

 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

 

Note 3. Cash and Cash Equivalents

           
  

March 31

2024

  

December 31

2023

 
Cash and cash equivalents          
  Cash and money market funds  $3,600,100   $2,269,200 
  $3,600,100   $2,269,200 

 

Note 4. Short-term Investments 

        
   March 31   December 31 
   2024   2023 
Short-term investments         
   U.S. Treasury Bills$ 6,910,900   $7,985,600 
   Short-term investments$ 6,910,900   $7,985,600 

 

 Schedule of amortized cost and fair value of securities held to maturity        
  

Amortized

Cost

  

Fair

Value

 
U.S. Treasury Bills          
Due April 18, 2024  $1,087,900   $1,122,200 
Due July 11, 2024   1074,800    1,108,800 
Due September 5, 2024   4,748,200    4,888,400 
    Total  $6,910,900   $7,119,400 

 

Total interest income recognized for U.S. Treasury Bills was $95,400 and $239,600 for the three months ended March 31, 2024 and year ended December 31, 2023. Interest receivable was $205,100 and $160,000 for the three months ended March 31, 2024 and for the year ended December 31, 2023. 

 

Note 5. Long-term Receivables

 

As of March 31, 2024, the Company had long-term receivables of $1,701,300 from two of the three licensees representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with two existing licensees and a license agreement with a new licensee. The receivable represents the present value of the fixed minimum annual payments due under the license agreements, discounted at the Company's incremental borrowing rate of 4%. 

 

The three agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

 

  · The royalty payment is fixed or determinable

 

  · Collection of the royalty payment is considered probable

 

  · The licensee has the ability to benefit from the licensed technology

 

The Company determined that the above conditions were met upon execution of the new 2022 license agreements and recognized $2,810,600 of royalty revenue net of imputed interest of $132,300 for the year ended December 31, 2022. The commissions are payable over the term of the license agreements and are due when payments are received by the Company. As of March 31, 2024, the accrued commission payable balance was approximately $161,200.

 

The current portion of the three license agreements in the amount of $604,800 and $624,600, is included in accounts receivable on the balance sheets as of March 31, 2024 and December 31, 2023, respectively.

 

 

6 
 

 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

  

The following table summarizes the future minimum payments due under the three license agreements as of March 31, 2024:

       
Year Ending December 31:        
  2024      $ 642,000  
  2025       570,000  
  2026       570,000  
  2027       557,500  
  2028       260,000  
     Total     $ 2,599,500  

 

The Company has evaluated the collectability of the long-term receivables and believes them to be fully collectible as of March 31, 2024. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors. 

 

The long-term receivables are recorded at its present value as of March 31, 2024, and will be amortized over the term of the license agreements using the effective interest method. The unamortized balance of the long-term receivables as of March 31, 2024 is $1,701,300.

 

Note 6. Line of Credit

 

In November 2018, our Company negotiated a $150,000 revolving line of credit with a bank to provide a source of working capital, if required. The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one-year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual review and quiet period. There have been no borrowings under the line of credit since its inception and the line of credit was terminated on July 13, 2023 

 

Note 7. Stockholders’ Equity

On September 11, 2023 our Company entered into a stock purchase agreement in connection with a private placement for total gross proceeds of $5.0 million. The stock purchase agreement provided for the issuance of an aggregate of 1,250,000 shares of our Company’s common stock to an investor at a purchase price of $4.00 per share. In addition, as consideration for general advisory services until the third anniversary, the Company agreed to issue an aggregate total of 65,790 shares of common stock with a total fair market value on date of grant of $263,160, which shares shall be issued as follows: one-third (21,930 shares) on September 11, 2024, one-third (21,930 shares) on September 11, 2025 and one-third (21,930 shares) on September 11, 2026. The Company expenses the value of the stock grant, which is determined to be the fair market value of the shares at the date of grant, straight-line over the term of the advisory agreement. For the year ended December 31, 2023, the Company recognized $26,600 of consulting expense associated with this issuance. On September 11, 2023, the sale pursuant to the Purchase Agreement closed. No placement fees or commissions were paid in connection with this transaction.

At March 31, 2024, our Company had no warrants outstanding.
7 
 

Note 8. Income Taxes

 

At March 31, 2024, there was no income tax benefit for the net losses for the three months ended March 31, 2024 due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. At March 31, 2023 our Company had federal and state taxable income of approximately $38,400 and $40,800, respectively. State income taxes in the three months ended March 31, 2023 resulted from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

 

The components for federal and state income tax expense are:

        
  

Three Months ended

March 31

 
   2024   2023 
Current federal taxes  $—     $8,100 
Current state taxes   —      2,400 
  $—     $10,500 

 

There was no change in unrecognized tax benefits during the period ended March 31, 2024 and there was no accrual for uncertain tax positions as of March 31, 2024. Tax years from 2021 through 2023 remain subject to examination by U.S. federal and state jurisdictions. The Federal net operating loss carryforward is $331,471 and the Pennsylvania State net operating loss carryforward is currently $1,911,568 as of March 31, 2024.

 

Note 9. Earnings (Loss) per Share

 

In accordance with FASB ASC 260, Earnings per Share, basic earnings (loss) per common share is computed using net earnings (loss) divided by the weighted average number of common shares outstanding for the periods presented. Diluted earnings (loss) per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Since our Company did not have any common stock equivalents outstanding as of March 31, 2024 and March 31, 2023, basic and diluted earnings (loss) per share were the same.

 

 
8 
 

 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

 

Note 10. Major Customer and Geographic Information

 

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:

        
  

Three Months ended

March 31

 
   2024   2023 
Customer A   68%   71%
Customer B   16%   12%

  

Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

        
   March 31   December 31 
    2024    2023 
Customer B   85%   82%

 

Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.

 

Our Company’s revenues by geographic region are as follows:

        
  

Three Months ended

March 31

 
   2024   2023 
North America  $77,700   $127,800 
Asia   302,000    441,500 
Australia   18,600    22,800 
   $398,300   $592,100 

  

 

9 
 

 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

  

Note 11. Leases

 

Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.  The lease has been extended for 13 months beginning on May 1, 2024 and expiring on May 31, 2025.

 

Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6.5%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

 

As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.

 

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

 

Total operating lease costs for each of the three month periods ended March 31, 2024 and March 31, 2023 was $13,300.

 

Maturities of lease liabilities were as follows:

    
    Operating Leases 
Year ending December 31     
2024  $4,700 
Total lease payments   4,700 
Less imputed interest   (300)
Total  $4,400 

 

 

  

10 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-Looking Information

 

This Report on Form 10-Q contains, and our officers and representatives may from time to time make, “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding:

 

  · Expected operating results, such as revenue, expenses and capital expenditures
  · Current or future volatility in market conditions
  · Our belief that we have sufficient liquidity to fund our business operations during the next twelve months
  · Strategy for customer retention, growth, product development, market position, and risk management

 

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

 

  · The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.
  · Strategic actions, including business acquisitions and our success in integrating acquired businesses.
  · Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.
  · The impact of losing our intellectual property protections or the loss in value of our intellectual property.
  · Changes in customer demand.
  · The occurrence of hostilities, political instability or catastrophic events.
  · Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.
  · Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.
  · Such other factors as discussed throughout Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q, and throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2023.

 

Any forward-looking statement made by us in this Report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

 

11 
 

 

The following discussion and analysis should be read in conjunction with our condensed financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management. This information should also be read in conjunction with our audited historical financial statements which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on March 25, 2024.

 

Background Overview

 

Nocopi Technologies, Inc. develops and markets specialty reactive inks for multiple applications across various industries. Our specialty inks are used by our customers for a range of purposes from bringing entertainment products to life with a variety of color activations to providing document and brand authentication for security purposes aimed at reducing losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. Our primary markets are the large educational and toy products industry and the document and product authentication industry. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.

 

Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation. 

 

Results of Operations

 

Our Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.

 

Our Company recognizes revenue on its lines of business as follows:

 

  a. License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;
  b. Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
  c. Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

 

We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.

 

Both the absolute amount of our Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on our Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when our Company agrees to revise such terms, revenues from the customer may be adversely affected.

 

12 
 

Revenues for the first quarter of 2024 were $398,300 compared to $592,100 in the first quarter of 2023, a decrease of $193,800, or approximately 33%. Licenses, royalties and fees decreased by $36,500, or approximately 30%, in the first quarter of 2024 to $86,500 from $123,000 in the first quarter of 2023. The decrease in licenses, royalties and fees in the first quarter of 2024 compared to the first quarter of 2023 is due primarily to lower royalties from our Company’s licensees in the entertainment and toy products market. We cannot assure you that the marketing and product development activities of our Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for our Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions presently being experienced.

 

Product and other sales decreased by $157,300, or approximately 34%, to $311,800 in the first quarter of 2024 from $469,100 in the first quarter of 2023. Sales of ink decreased in the first quarter of 2024 compared to the first quarter of 2023 due primarily to lower ink shipments to the third party authorized printer used by two of our Company’s major licensees in the entertainment and toy products market. In the first quarter of 2024, our Company derived revenues of approximately $364,700 from our Company’s licensees and their authorized printers in the entertainment and toy products market compared to revenues of approximately $541,500 in the first quarter of 2023.

 

Our Company’s gross profit decreased to $165,600, or approximately 42% of gross revenues, in the first quarter of 2024 from $311,600, or approximately 53% of gross revenues, in the first quarter of 2023 due to decrease in both licenses, royalties and fees and product and other sales revenues. Licenses, royalties and fees have historically carried a higher gross profit than product and other sales, which generally consist of either supplies or other manufactured products which incorporate our Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by our Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. 

  

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both the gross profit from these sources as well as our Company’s overall gross profit. The gross profit from licenses, royalties and fees decreased to approximately 40% in the first quarter of 2024 from approximately 52% in the first quarter of 2023.

 

The gross profit of product and other sales, expressed as a percentage of revenues, is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. Primarily due to lower sales of ink and other products in the first quarter of 2024 compared to the first quarter of 2023, there was a lower gross profit from product and other sales of approximately 42% of revenues in the first quarter of 2024 compared to a gross profit of approximately 53% of revenues in the first quarter of 2023.

 

Research and development expenses decreased in the first quarter of 2024 to $41,400 compared to $44,800 in the first quarter of 2023 due primarily to lower lab expenses in the first quarter of 2024 compared to the first quarter of 2023.

 

Sales and marketing expenses decreased to $69,000 in the first quarter of 2024 from $86,300 in the first quarter of 2023 due primarily to lower commission expense on the lower level of revenues in the first quarter of 2024 compared to the first quarter of 2023.

 

General and administrative expenses increased in the first quarter of 2024 to $1,214,800 compared to $201,200 in the first quarter of 2023 due primarily to higher stock-based compensation, higher professional fees, and higher employee related expenses in the first quarter of 2024 compared to the first quarter of 2023.

 

For the first quarter of 2024, there was no income tax benefit for the net losses for the first quarter of 2024 due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. Income taxes in the first quarter of 2023 include federal and state income taxes. The state income taxes result from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

 

The net loss of $1,028,200 in the first quarter of 2024 compared to the net income of $30,300 in the first quarter of 2023 resulted primarily from a lower gross profit on a lower level of licenses, royalties and fees and product sales, higher operating expenses and interest income in the first quarter of 2024 compared to the first quarter of 2023.

 

 

13 
 

Plan of Operation, Liquidity and Capital Resources

 

During the first quarter of 2024, our Company’s cash increased to $3,600,100 at March 31, 2024 from $2,269,200 at December 31, 2023. During the first quarter of 2023, our Company generated $264,200 from its operating activities and provided $1,066,700, from investing activities. 

 

During the first quarter of 2024, our Company’s revenues decreased approximately 33% primarily as a result of lower sales of ink to an authorized printer of our Company’s licensees in the entertainment and toy products market and lower royalty revenues from our Company’s licensees in the entertainment and toy products market. Our total overhead expenses increased in the first quarter of 2024 to $1,325,200 compared to $332,300 in the first quarter of 2023, our Company’s interest income increased and our Company’s income tax expense decreased in the first quarter of 2024 compared to the first quarter of 2023. As a result of these factors, our Company generated a net loss of $1,028,200 in the first quarter of 2024 compared to net income of $30,300 in the first quarter of 2023. Our Company had positive operating cash flow of $264,200 during the first quarter of 2024. At March 31, 2024, our Company had working capital of $9,737,300 and stockholders’ equity of $11,354,300. For the full year of 2023, our Company had a net loss of $1,435,900 and had negative operating cash flow of $19,300. At December 31, 2023, our Company had working capital of $10,618,500 and stockholders’ equity of $12,382,500. 

 

Our plan of operation for the twelve months beginning with the date of this Quarterly Report on Form 10-Q consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships our Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating the Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with our Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.

 

Our Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable our Company to generate additional revenues and positive cash flow.

 

Our future growth strategy includes expanding our business through acquisitions of other companies with competing or complementary services, technologies or businesses in order to expand our product and service offerings to grow our free cash flow. We are currently actively engaged in the process to identify acquisition candidates and negotiate transactions. As of the date of this Quarterly Report on Form 10-Q, we have no agreements to make any acquisition. We expect to fund our business expansion through the issuance of debt or equity securities, the payment of cash, the exchange of services, or any combination thereof.

 

Our Company has received, and may in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirements and to provide funding for other business opportunities., We cannot assure you that if we require additional capital, that we will be successful in obtaining such additional capital, or that such additional capital, if obtained, will enable our Company to generate additional revenues and positive cash flow.

 

As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment in 2024 and beyond due to any future effects of the COVID-19 pandemic and its effect on the global economy, geopolitical instability including the ongoing conflict between Russia and Ukraine and the supply chain disruptions related to both as well as the record inflation, lower demand and significantly higher interest rates currently being experienced in the United States along with the probability of an economic recession both in the United States and globally.. As a result, our revenues, results of operations and liquidity may be negatively impacted in future periods.

 

 

14 
 

Contractual Obligations

 

As of March 31, 2024, there were no material changes in our contractual obligations from those disclosed in our Annual Report on Form 10-K filed with the SEC on March 25, 2024, other than those appearing in the notes to the financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

 

Recently Adopted Accounting Pronouncements

 

As of March 31, 2024 and for the period then ended, there are no recently adopted accounting standards that have a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

 

As of March 31, 2024, there were no recently issued accounting standards not yet adopted that would have a material effect on our Company’s financial statements.

 

Off-Balance Sheet Arrangements

 

Our Company does not have any off-balance sheet arrangements.

  

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not Applicable

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures. Our Company’s management, with the participation of our Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of March 31, 2024. Based on this evaluation, our Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of March 31, 2024, our Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by our Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to our Company’s management, including our Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 

15 
 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None

 

Item 1A. Risk Factors.

 

Information about risk factors for the quarter ended March 31, 2024 does not differ materially from that set forth in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None 

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not applicable

 

Item 5.  Other Information.

 

From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend or terminate written trading arrangements pursuant to Rule 10b5-1 of the Securities and Exchange Act or otherwise.

 

For the quarter ended March 31, 2024, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.

 

Item 6.  Exhibits.

 

(a) Exhibits

 

The following exhibits are included herein:

 

Exhibit Number   Description   Location
31.1   Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith
31.2   Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith
32.1   Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Furnished herewith
101.INS   Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document   Filed herewith
101.SCH   Inline XBRL Taxonomy Extension Schema   Filed herewith
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase   Filed herewith
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase   Filed herewith
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase   Filed herewith
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase   Filed herewith
104   Cover page formatted as Inline XBRL and contained in Exhibit 101   Filed herewith

 

 

 

16 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    NOCOPI TECHNOLOGIES, INC.
     
DATE: May 15, 2024   /s/ Michael S. Liebowitz
    Michael S.Liebowitz
    Chairman of the Board, President & Chief Executive Officer (Principal Executive Officer)
     
DATE: May 15, 2024   /s/ Debra E. Glickman
     Debra E. Glickman
     Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

17 
 

 

 

 

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

I, Michael S. Liebowitz, Chief Executive Officer of Nocopi Technologies, Inc., certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024 

 

/s/ Michael S. Liebowitz

Michael S. Liebowitz

Chief Executive Officer

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

I, Debra E. Glickman, Chief Financial Officer of Nocopi Technologies, Inc., certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024 

 

/s/ Debra E. Glickman

Debra E. Glickman

Chief Financial Officer

Exhibit 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Nocopi Technologies, Inc. (the "Company") on Form 10-Q for the Quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Michael S. Liebowitz, Chief Executive Officer, and Debra E. Glickman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

 

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

May 15, 2024 

 

/s/ Michael S. Liebowitz

Michael S. Liebowitz

Chief Executive Officer (Principal Executive Officer)

 

/s/ Debra E. Glickman

Debra E. Glickman

Chief Financial Officer (Principal Financial Officer)

v3.24.1.1.u2
Cover - shares
 3 Months Ended
Mar. 31, 2024
May 08, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 000-20333  
Entity Registrant Name NOCOPI TECHNOLOGIES, INC.  
Entity Central Index Key 0000888981  
Entity Tax Identification Number 87-0406496  
Entity Incorporation, State or Country Code MD  
Entity Address, Address Line One 480 Shoemaker Road  
Entity Address, Address Line Two Suite 104  
Entity Address, City or Town King of Prussia  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19406  
City Area Code (610)  
Local Phone Number 834-9600  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,501,178
v3.24.1.1.u2
Statements of Comprehensive Income (Loss) (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Licenses, royalties and fees $ 86,500 $ 123,000
Product and other sales 311,800 469,100
 Total revenues 398,300 592,100
Cost of revenues    
Licenses, royalties and fees 51,800 58,700
Product and other sales 180,900 221,800
Total cost of revenues 232,700 280,500
Gross profit 165,600 311,600
Operating expenses    
Research and development 41,400 44,800
Sales and marketing 69,000 86,300
General and administrative 1,214,800 201,200
Total operating expenses 1,325,200 332,300
Net loss from operations (1,159,600) (20,700)
Other income (expenses)    
Interest income 137,100 62,100
Interest expense and bank charges (5,700) (600)
Total other income (expenses) 131,400 61,500
Net income (loss) before income taxes (1,028,200) 40,800
Income taxes 10,500
Net income (loss) $ (1,028,200) $ 30,300
Basic net income (loss) per common share $ (0.10) $ 0.00
Diluted net income (loss) per common share $ (0.10) $ 0.00
Weighted average common shares outstanding    
Basic 10,501,178 9,251,178
Diluted 10,501,178 9,251,178
v3.24.1.1.u2
Balance Sheets (unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 3,600,100 $ 2,269,200
Accounts receivable less $12,000 allowance for credit losses 981,500 1,120,700
Inventory 370,300 448,000
Interest receivable 205,100 160,000
Short-term investments 6,910,900 7,985,600
Prepaid and other 100,600 121,800
Total current assets 12,168,500 12,105,300
Fixed assets    
Leasehold improvements 81,500 81,500
Furniture, fixtures and equipment 177,800 169,800
Fixed assets, gross 259,300 251,300
Less: accumulated depreciation and amortization 229,000 214,800
 Total fixed assets 30,300 36,500
Other assets    
Long-term receivables 1,701,300 1,838,500
Operating lease right of use – building 4,400 17,600
Total other assets 1,705,700 1,856,100
Total assets 13,904,500 13,997,900
Current liabilities    
Accounts payable 47,700 27,500
Accrued expenses 120,000 94,600
Stock compensation payable 2,259,100 1,347,100
Operating lease liability – current 4,400 17,600
Total current liabilities 2,431,200 1,486,800
Other liabilities    
Accrued expenses, non-current 119,000 128,600
Total other liabilities 119,000 128,600
Stockholders' equity    
Common stock, $0.01 par value Authorized – 75,000,000 shares Issued and outstanding – 10,501,178 shares 105,000 105,000
Paid-in capital 21,647,100 21,647,100
Accumulated deficit (10,397,800) (9,369,600)
Total stockholders' equity 11,354,300 12,382,500
Total liabilities and stockholders' equity $ 13,904,500 $ 13,997,900
v3.24.1.1.u2
Balance Sheets (unaudited) (Parenthetical) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 12,000 $ 12,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 10,501,178 10,501,178
Common stock, shares outstanding 10,501,178 10,501,178
v3.24.1.1.u2
Statements of Cash Flows (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
     Net income (loss) $ (1,028,200) $ 30,300
     Adjustments to reconcile net income (loss) to net cash provided by operating activities    
           Depreciation and amortization 14,200 8,300
           Stock-based compensation 912,000
           Interest income accrued (45,100)
    (Increase) decrease in assets    
          Accounts receivable 139,200 (163,700)
          Inventory 77,700 81,000
          Prepaid and other 21,200 (56,700)
          Long-term receivables 150,400 169,400
    Increase (decrease) in liabilities    
          Accounts payable and accrued expenses 22,800 (21,500)
          Income taxes 10,500
          Net cash provided by operating activities 264,200 57,600
Investing Activities    
Additions to fixed assets (8,000) (1,100)
Sale of short-term investments 1,074,700
Net cash provided by (used in) investing activities 1,066,700 (1,100)
Increase in cash and cash equivalents 1,330,900 56,500
Cash and Cash Equivalents    
 Beginning of year 2,269,200 5,337,800
 End of period $ 3,600,100 $ 5,394,300
v3.24.1.1.u2
Statements of Stockholders' Equity (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 92,500 $ 16,659,600 $ (7,933,700) $ 8,818,400
Beginning balance, shares at Dec. 31, 2022 9,251,178      
Net income 30,300 30,300
Ending balance, value at Mar. 31, 2023 $ 92,500 16,659,600 (7,903,400) 8,848,700
Ending balance, shares at Mar. 31, 2023 9,251,178      
Beginning balance, value at Dec. 31, 2023 $ 105,000 21,647,100 (9,369,600) 12,382,500
Beginning balance, shares at Dec. 31, 2023 10,501,178      
Net income (1,028,200) (1,028,200)
Ending balance, value at Mar. 31, 2024 $ 105,000 $ 21,647,100 $ (10,397,800) $ 11,354,300
Ending balance, shares at Mar. 31, 2024 10,501,178      
v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ (1,028,200) $ 30,300
v3.24.1.1.u2
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual [Table]  
Material Terms of Trading Arrangement

From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend or terminate written trading arrangements pursuant to Rule 10b5-1 of the Securities and Exchange Act or otherwise.

 

For the quarter ended March 31, 2024, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.1.u2
Financial Statements
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Financial Statements

Note 1. Financial Statements

 

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (our “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in Note 2 Significant Accounting Policies included in the Notes to Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 25, 2024 (the “2023 Annual Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 2023 Annual Report should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months ended March 31, 2024 may not be necessarily indicative of the operating results expected for the full year. 

 

Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income (loss).  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since our Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

 

Recently Issued Accounting Pronouncements Not Yet Adopted

As of March 31, 2024, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Recently Adopted Accounting Pronouncements

As of March 31, 2024 and for the period then ended, there are no recently adopted accounting standards that have a material effect on the Company's financial statements.
v3.24.1.1.u2
Stock-Based Compensation
 3 Months Ended
Mar. 31, 2024
Compensation Related Costs [Abstract]  
Stock-Based Compensation

Note 2. Stock-Based Compensation

 

Our Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. At March 31, 2024, our Company did not have an active stock option plan. There was no unrecognized portion of expense related to stock option grants at March 31, 2024.

 

As part of an employment agreement, the Company granted an executive a one-time equity award of 1,000,000 restricted shares of the Company’s common stock valued at $3,580,000, fair value, which award shall vest in its entirety on August 18, 2024. The fair market value of the restricted stock award was determined based on the closing price of the Company’s common stock on the grant date and is being amortized on a straight-line basis to general and administrative expense as stock-based compensation over the one-year vesting term. The Company recorded stock-based compensation expense of $890,100 for the three months ended March 31, 2024. To the extent the Company has not established an employee equity compensation plan on or prior to August 18, 2024, the restricted shares may be converted, at the election of the executive, in full or in part, into cash compensation, at a rate of $3.58 per share of common stock, which was the fair market value of the common stock on October 10, 2023, which was the date the Board of Directors approved the grant. Since the issuance of the restricted stock can be settled in cash, the monthly amortization of the $3,580,000 fair value of the restricted stock grant is recorded as stock compensation payable. If the restricted stock grant is settled in shares of the Company’s common stock, then the stock compensation payable will be reclassified to additional paid in capital.

 
v3.24.1.1.u2
Cash and Cash Equivalents
 3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents

Note 3. Cash and Cash Equivalents

           
  

March 31

2024

  

December 31

2023

 
Cash and cash equivalents          
  Cash and money market funds  $3,600,100   $2,269,200 
  $3,600,100   $2,269,200 

 
v3.24.1.1.u2
Short-term Investments
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Short-term Investments

Note 4. Short-term Investments 

        
   March 31   December 31 
   2024   2023 
Short-term investments         
   U.S. Treasury Bills$ 6,910,900   $7,985,600 
   Short-term investments$ 6,910,900   $7,985,600 

 

 Schedule of amortized cost and fair value of securities held to maturity        
  

Amortized

Cost

  

Fair

Value

 
U.S. Treasury Bills          
Due April 18, 2024  $1,087,900   $1,122,200 
Due July 11, 2024   1074,800    1,108,800 
Due September 5, 2024   4,748,200    4,888,400 
    Total  $6,910,900   $7,119,400 

 

Total interest income recognized for U.S. Treasury Bills was $95,400 and $239,600 for the three months ended March 31, 2024 and year ended December 31, 2023. Interest receivable was $205,100 and $160,000 for the three months ended March 31, 2024 and for the year ended December 31, 2023. 

 
v3.24.1.1.u2
Long-term Receivables
 3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Long-term Receivables

Note 5. Long-term Receivables

 

As of March 31, 2024, the Company had long-term receivables of $1,701,300 from two of the three licensees representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with two existing licensees and a license agreement with a new licensee. The receivable represents the present value of the fixed minimum annual payments due under the license agreements, discounted at the Company's incremental borrowing rate of 4%. 

 

The three agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

 

  · The royalty payment is fixed or determinable

 

  · Collection of the royalty payment is considered probable

 

  · The licensee has the ability to benefit from the licensed technology

 

The Company determined that the above conditions were met upon execution of the new 2022 license agreements and recognized $2,810,600 of royalty revenue net of imputed interest of $132,300 for the year ended December 31, 2022. The commissions are payable over the term of the license agreements and are due when payments are received by the Company. As of March 31, 2024, the accrued commission payable balance was approximately $161,200.

 

The current portion of the three license agreements in the amount of $604,800 and $624,600, is included in accounts receivable on the balance sheets as of March 31, 2024 and December 31, 2023, respectively.

 

  

The following table summarizes the future minimum payments due under the three license agreements as of March 31, 2024:

       
Year Ending December 31:        
  2024      $ 642,000  
  2025       570,000  
  2026       570,000  
  2027       557,500  
  2028       260,000  
     Total     $ 2,599,500  

 

The Company has evaluated the collectability of the long-term receivables and believes them to be fully collectible as of March 31, 2024. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors. 

 

The long-term receivables are recorded at its present value as of March 31, 2024, and will be amortized over the term of the license agreements using the effective interest method. The unamortized balance of the long-term receivables as of March 31, 2024 is $1,701,300.

 
v3.24.1.1.u2
Line of Credit
 3 Months Ended
Mar. 31, 2024
Line Of Credit  
Line of Credit

Note 6. Line of Credit

 

In November 2018, our Company negotiated a $150,000 revolving line of credit with a bank to provide a source of working capital, if required. The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one-year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual review and quiet period. There have been no borrowings under the line of credit since its inception and the line of credit was terminated on July 13, 2023 

 
v3.24.1.1.u2
Stockholders’ Equity
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Stockholders’ Equity

Note 7. Stockholders’ Equity

On September 11, 2023 our Company entered into a stock purchase agreement in connection with a private placement for total gross proceeds of $5.0 million. The stock purchase agreement provided for the issuance of an aggregate of 1,250,000 shares of our Company’s common stock to an investor at a purchase price of $4.00 per share. In addition, as consideration for general advisory services until the third anniversary, the Company agreed to issue an aggregate total of 65,790 shares of common stock with a total fair market value on date of grant of $263,160, which shares shall be issued as follows: one-third (21,930 shares) on September 11, 2024, one-third (21,930 shares) on September 11, 2025 and one-third (21,930 shares) on September 11, 2026. The Company expenses the value of the stock grant, which is determined to be the fair market value of the shares at the date of grant, straight-line over the term of the advisory agreement. For the year ended December 31, 2023, the Company recognized $26,600 of consulting expense associated with this issuance. On September 11, 2023, the sale pursuant to the Purchase Agreement closed. No placement fees or commissions were paid in connection with this transaction.

At March 31, 2024, our Company had no warrants outstanding.
v3.24.1.1.u2
Income Taxes
 3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

Note 8. Income Taxes

 

At March 31, 2024, there was no income tax benefit for the net losses for the three months ended March 31, 2024 due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. At March 31, 2023 our Company had federal and state taxable income of approximately $38,400 and $40,800, respectively. State income taxes in the three months ended March 31, 2023 resulted from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

 

The components for federal and state income tax expense are:

        
  

Three Months ended

March 31

 
   2024   2023 
Current federal taxes  $—     $8,100 
Current state taxes   —      2,400 
  $—     $10,500 

 

There was no change in unrecognized tax benefits during the period ended March 31, 2024 and there was no accrual for uncertain tax positions as of March 31, 2024. Tax years from 2021 through 2023 remain subject to examination by U.S. federal and state jurisdictions. The Federal net operating loss carryforward is $331,471 and the Pennsylvania State net operating loss carryforward is currently $1,911,568 as of March 31, 2024.

 
v3.24.1.1.u2
Earnings (Loss) per Share
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings (Loss) per Share

Note 9. Earnings (Loss) per Share

 

In accordance with FASB ASC 260, Earnings per Share, basic earnings (loss) per common share is computed using net earnings (loss) divided by the weighted average number of common shares outstanding for the periods presented. Diluted earnings (loss) per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Since our Company did not have any common stock equivalents outstanding as of March 31, 2024 and March 31, 2023, basic and diluted earnings (loss) per share were the same.

 
v3.24.1.1.u2
Major Customer and Geographic Information
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Major Customer and Geographic Information

Note 10. Major Customer and Geographic Information

 

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:

        
  

Three Months ended

March 31

 
   2024   2023 
Customer A   68%   71%
Customer B   16%   12%

  

Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

        
   March 31   December 31 
    2024    2023 
Customer B   85%   82%

 

Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.

 

Our Company’s revenues by geographic region are as follows:

        
  

Three Months ended

March 31

 
   2024   2023 
North America  $77,700   $127,800 
Asia   302,000    441,500 
Australia   18,600    22,800 
   $398,300   $592,100 

  

 
v3.24.1.1.u2
Leases
 3 Months Ended
Mar. 31, 2024
Leases  
Leases

Note 11. Leases

 

Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.  The lease has been extended for 13 months beginning on May 1, 2024 and expiring on May 31, 2025.

 

Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6.5%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

 

As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.

 

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

 

Total operating lease costs for each of the three month periods ended March 31, 2024 and March 31, 2023 was $13,300.

 

Maturities of lease liabilities were as follows:

    
    Operating Leases 
Year ending December 31     
2024  $4,700 
Total lease payments   4,700 
Less imputed interest   (300)
Total  $4,400 
v3.24.1.1.u2
Cash and Cash Equivalents (Tables)
 3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents
           
  

March 31

2024

  

December 31

2023

 
Cash and cash equivalents          
  Cash and money market funds  $3,600,100   $2,269,200 
  $3,600,100   $2,269,200 
v3.24.1.1.u2
Short-term Investments (Tables)
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of short term investments
        
   March 31   December 31 
   2024   2023 
Short-term investments         
   U.S. Treasury Bills$ 6,910,900   $7,985,600 
   Short-term investments$ 6,910,900   $7,985,600 
Short-term Investments (Details 1)
 Schedule of amortized cost and fair value of securities held to maturity        
  

Amortized

Cost

  

Fair

Value

 
U.S. Treasury Bills          
Due April 18, 2024  $1,087,900   $1,122,200 
Due July 11, 2024   1074,800    1,108,800 
Due September 5, 2024   4,748,200    4,888,400 
    Total  $6,910,900   $7,119,400 
v3.24.1.1.u2
Long-term Receivables (Tables)
 3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Schedule of future minimum payments
       
Year Ending December 31:        
  2024      $ 642,000  
  2025       570,000  
  2026       570,000  
  2027       557,500  
  2028       260,000  
     Total     $ 2,599,500  
v3.24.1.1.u2
Income Taxes (Tables)
 3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of federal and state income tax expense
        
  

Three Months ended

March 31

 
   2024   2023 
Current federal taxes  $—     $8,100 
Current state taxes   —      2,400 
  $—     $10,500 
v3.24.1.1.u2
Major Customer and Geographic Information (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of revenues as percentage of revenue
        
  

Three Months ended

March 31

 
   2024   2023 
Customer A   68%   71%
Customer B   16%   12%
Schedule of non-affiliated customers with accounts receivable
        
   March 31   December 31 
    2024    2023 
Customer B   85%   82%
Schedule of revenue by geographic region
        
  

Three Months ended

March 31

 
   2024   2023 
North America  $77,700   $127,800 
Asia   302,000    441,500 
Australia   18,600    22,800 
   $398,300   $592,100 
v3.24.1.1.u2
Leases (Tables)
 3 Months Ended
Mar. 31, 2024
Leases  
Schedule of maturities of lease liabilities
    
    Operating Leases 
Year ending December 31     
2024  $4,700 
Total lease payments   4,700 
Less imputed interest   (300)
Total  $4,400 
v3.24.1.1.u2
Stock-Based Compensation (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2024
Aug. 18, 2024
Unrecognized portion of expense related to stock option grants $ 0  
Stock based compensation expense 890,100  
Amortization $ 3,580,000  
Common Stock [Member]    
Restricted shares 1,000,000  
Restricted value $ 3,580,000  
Common stock price per share   $ 3.58
v3.24.1.1.u2
Cash and Cash Equivalents (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]    
Cash and money market funds $ 3,600,100 $ 2,269,200
Cash and cash equivalents $ 3,600,100 $ 2,269,200
v3.24.1.1.u2
Short-term Investments (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
U.S. Treasury Bills $ 6,910,900 $ 7,985,600
Short-term investments $ 6,910,900 $ 7,985,600
v3.24.1.1.u2
Short-term Investments (Details 1)
Mar. 31, 2024
USD ($)
Cash and Cash Equivalents [Line Items]  
Amortized Cost $ 6,910,900
Fair Value 7,119,400
Due April [Member]  
Cash and Cash Equivalents [Line Items]  
Amortized Cost 1,087,900
Fair Value 1,122,200
Due July [Member]  
Cash and Cash Equivalents [Line Items]  
Amortized Cost 1,074,800
Fair Value 1,108,800
Due September [Member]  
Cash and Cash Equivalents [Line Items]  
Amortized Cost 4,748,200
Fair Value $ 4,888,400
v3.24.1.1.u2
Short-term Investments (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Debt Disclosure [Abstract]      
U.S Treasury bills interest income $ 95,400 $ 239,600  
Interest receivable $ 205,100   $ 160,000
v3.24.1.1.u2
Long-term Receivables (Details)
Mar. 31, 2024
USD ($)
Receivables [Abstract]  
2024 $ 642,000
2025 570,000
2026 570,000
2027 557,500
2028 260,000
Total $ 2,599,500
v3.24.1.1.u2
Long-term Receivables (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 31, 2024
Dec. 31, 2023
Receivables [Abstract]      
Long-term receivables   $ 1,701,300 $ 1,838,500
Incremental borrowing rate   4.00%  
Royalty Income, Nonoperating $ 2,810,600    
Receivable with Imputed Interest, Net Amount     132,300
Accrued Sales Commission, Current   $ 161,200  
Accounts receivable, current   604,800 $ 624,600
Accounts receivable, long-term   $ 1,701,300  
v3.24.1.1.u2
Line of Credit (Details Narrative)
 3 Months Ended
Mar. 31, 2024
USD ($)
Line Of Credit  
Line of credit facility, maximum borrowing capacity $ 150,000
Line of credit facility, interest rate description The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one-year and its prime rate plus 1.5% thereafter.
v3.24.1.1.u2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended
Sep. 11, 2023
Mar. 31, 2024
Subsidiary, Sale of Stock [Line Items]    
Proceeds from Issuance or Sale of Equity $ 5,000,000.0  
[custom:AggregateSharesIssued-0] 65,790  
[custom:FairMarketValue-0] $ 263,160  
[custom:ConsultingExpenses]   $ 26,600
Warrants outstanding   0
Private Placement [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock Issued During Period, Shares, New Issues 1,250,000  
Share Price $ 4.00  
v3.24.1.1.u2
Income Taxes (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Current federal tax benefit $ 8,100
Current state tax benefit 2,400
Income tax expense (benefit) $ 10,500
v3.24.1.1.u2
Income Taxes (Details Narrative)
Mar. 31, 2024
USD ($)
Effective Income Tax Rate Reconciliation [Line Items]  
Unrecognized tax benefits $ 0
Accrual for uncertain tax positions 0
Domestic Tax Jurisdiction [Member]  
Effective Income Tax Rate Reconciliation [Line Items]  
Net operating loss carryforwards 331,471
State and Local Jurisdiction [Member]  
Effective Income Tax Rate Reconciliation [Line Items]  
Net operating loss carryforwards $ 1,911,568
v3.24.1.1.u2
Major Customer and Geographic Information (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Customer A [Member]    
Revenue, Major Customer [Line Items]    
Risk percentage 68.00% 71.00%
Customer B [Member]    
Revenue, Major Customer [Line Items]    
Risk percentage 16.00% 12.00%
v3.24.1.1.u2
Major Customer and Geographic Information (Details 1)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Customer B [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Risk percentage 85.00% 82.00%
v3.24.1.1.u2
Major Customer and Geographic Information (Details 2) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 398,300 $ 592,100
North America [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 77,700 127,800
Asia [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 302,000 441,500
AUSTRALIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 18,600 $ 22,800
v3.24.1.1.u2
Leases (Details) - USD ($)
Mar. 31, 2024
Jan. 01, 2019
Leases    
2024 $ 4,700  
Total lease payments 4,700  
Less imputed interest (300)  
Total $ 4,400 $ 241,100
v3.24.1.1.u2
Leases (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jan. 01, 2019
Leases        
Incremental borrowing rate       6.50%
Operating lease right-of-use asset $ 4,400   $ 17,600 $ 241,100
Operating lease liability 4,400     $ 241,100
Operating lease cost $ 13,300 $ 13,300    
Nocopi Technologies Inc MD (QB) (USOTC:NNUP)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Nocopi Technologies Inc MD (QB) Charts.
Nocopi Technologies Inc MD (QB) (USOTC:NNUP)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Nocopi Technologies Inc MD (QB) Charts.